Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes

The Journal of Dermatology
Keisuke NakaseNorihisa Noguchi

Abstract

Antimicrobial agents have been used for eradication of Cutibacterium (formerly Propionibacterium) acnes that is an exacerbation factor of the skin disease acne vulgaris. However, the use of antibiotics is associated with an increased risk of promoting the emergence of resistant bacteria and leading to skin dysbiosis. Traditional Japanese Kampo medicines, such as Keigairengyoto, are used to treat acne. However, there is incomplete understanding regarding their functional mechanism in treatment of acne. In this study, we examined the antimicrobial and anti-lipase activity of the Kampo medicines used empirically for acne treatment. Three oral medicines, Keigairengyoto, Seijoboufuto and Jumihaidokuto, were found to inhibit the growth of C. acnes and decrease the lipase activity. Especially, Keigairengyoto caused remarkable decrease of bacterial lipase activity. Furthermore, topical medicines such as Shiunko and Chuoko significantly decreased the lipase activity in a dose-dependent manner, without inhibiting C. acnes growth. The topical medicines were found to inhibit the expression of gehA, which codes for extracellular lipase. Our results indicate that Shiunko and Chuoko have potential as effective acne therapeutic agents, especia...Continue Reading

References

Dec 1, 1998·International Journal of Antimicrobial Agents·S HigakiT Yamagishi
Aug 12, 2004·JAMA : the Journal of the American Medical Association·Aamir Haider, James C Shaw
May 30, 2009·Science·Elizabeth A GriceJulia A Segre
Mar 17, 2010·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N R Srinivas
Jan 25, 2012·International Journal of Cosmetic Science·V PatilD Debjani
Apr 3, 2013·Chemical & Pharmaceutical Bulletin·Chi-Hsien Liu, Hsin-Ying Huang
Jan 24, 2014·Microbiome·Alexander V AlekseyenkoMartin J Blaser
Nov 5, 2014·Acta Dermato-venereologica·Laurent MiseryCharles Taïeb
Jun 4, 2015·Acta Dermato-venereologica·Gábor TaxKornélia Szabó
Aug 13, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Young-Seob LeeSin-Hee Han
Nov 16, 2016·BMC Complementary and Alternative Medicine·Tetsuya YamadaNorihisa Noguchi
May 22, 2018·The Journal of Dermatology·Nobukazu HayashiMakoto Kawashima

❮ Previous
Next ❯

Citations

Feb 2, 2021·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Norihisa Noguchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

International Journal of Antimicrobial Agents
S HigakiT Yamagishi
Dermatology : International Journal for Clinical and Investigative Dermatology
K T HollandC Walters
Acta Dermato-venereologica. Supplementum
J J LeydenA M Kligman
The Journal of Antimicrobial Chemotherapy
S J AdamsW J Cunliffe
© 2022 Meta ULC. All rights reserved